Research output per year
Research output per year
Personal profile
Research Interests
Radiotherapy and metabolism, Molecular Imaging, Radiobiology
Education/Academic qualification
PhD, Life Sciences, National Defense University
Fingerprint
Dive into the research topics where Yu-Chan Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ALDOA coordinates PDE3A through the β-catenin/ID3 axis to stimulate cancer metastasis and M2 polarization in lung cancer with EGFR mutations
Yeh, C. Y., Cai, H. Y., Kuo, H. H., Lin, Y. Y., He, Z. J., Cheng, H. C., Yang, C. J., Huang, C. Y. F. & Chang, Y. C., 12 Feb 2024, In: Biochemical and Biophysical Research Communications. 696, 149489.Research output: Contribution to journal › Article › peer-review
-
CD47-mediated immune evasion in early-stage lung cancer progression
Chuang, C. H., Zhen, Y. Y., Ma, J. Y., Lee, T. H., Hung, H. Y., Wu, C. C., Wang, P. H., Huang, C. T., Huang, M. S., Hsiao, M., Lee, Y. R., Huang, C. Y. F., Chang, Y. C. & Yang, C. J., 6 Aug 2024, In: Biochemical and Biophysical Research Communications. 720, 150066.Research output: Contribution to journal › Article › peer-review
-
Dawn era for revisited cancer therapy by innate immune system and immune checkpoint inhibitors
Kim, H. D., Yeh, C. Y., Chang, Y. C. & Kim, C. H., Mar 2024, In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1870, 3, 167019.Research output: Contribution to journal › Review article › peer-review
-
Magnetically Guided Theranostics: Novel Nanotubular Magnetic Resonance Imaging Contrast System Using Halloysite Nanotubes Embedded with Iron–Platinum Nanoparticles for Hepatocellular Carcinoma Treatment
Chan, M. H., Lee, C. Y., Li, C. H., Chang, Y. C., Wei, D. H. & Hsiao, M., Aug 2024, In: Small Structures. 5, 8, 2300526.Research output: Contribution to journal › Article › peer-review
Open Access -
PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression
Chang, Y. C., Chan, M. H., Li, C. H., Chen, C. L., Tsai, W. C. & Hsiao, M., Dec 2024, In: Cell Communication and Signaling. 22, 1, 266.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations